StonvexLoading…
StonvexStonvexStonvexCore line items from FNWD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $22.72M | $91.76M | $68.35M | $45.01M |
Operating Income | $2.67M | $8.11M | $6.29M | $2.73M |
Net Income | $2.24M | $8.09M | $6.10M | $2.61M |
EPS (Diluted) | $0.52 | $1.88 | $1.42 | $0.61 |
Total Assets | $2.02B | $2.02B | $2.05B | $2.06B |
Total Liabilities | $1.84B | $1.85B | $1.89B | $1.90B |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $3.50M | $9.05M | $1.55M | $499.00K |
Shares Outstanding | 4.33M | 4.33M | 4.33M | 4.32M |